Search In this Thesis
   Search In this Thesis  
العنوان
Expression of Placental Osteoprotegerin in Preeclampsia, Case-control Study/
المؤلف
Abdoun,Yasmin Mohamed El Sayed Mohamed
هيئة الاعداد
باحث / ياسمين محمد السيد محمد عبدون
مشرف / محمد محمود الشربيني
مشرف / محمد سعيد خلاف
مشرف / مي أحمد إبراهيم محمد
مشرف / روان محمود محمد متولي
تاريخ النشر
2023
عدد الصفحات
186.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
أمراض النساء والتوليد
تاريخ الإجازة
1/1/2023
مكان الإجازة
جامعة عين شمس - كلية الطب - Obstetrics and Gynecololgy
الفهرس
Only 14 pages are availabe for public view

from 184

from 184

Abstract

Osteoprotegerin (OPG), a key regulatory factor in bone metabolism, was documented also as a proangiogenic factor, which acts an important role in protecting vascular endothelial cells. Since preeclampsia has gradually been employed to be vascular diseases, we speculated that OPG might be associated with preeclampsia. So this study is to investigate the relationship between OPG and the pathogenesis of preeclampsia.
Objective: To correlate expression of osteoprotegerin in placenta and its association with preeclampsia. Also; if osteoprotegerin level in placenta differs with severity whether mild or severe case
Subjects and Methods: Our study is a prospective case-control study which conducted at tertiary care hospital at Ain Shams University hospital. It was performed on total of 90 patients whom 30 patients diagnosed as severe preeclampsia, 30 patients diagnosed as mild preeclampsia and 30 patients as control healthy pregnant to assess the change in osteoprotegerin level in placental tissue in preeclampsia patients by: ELISA: to detect OPG protein level. Real time PCR: to detect OPG mRNA.
Results: In this study, by comparing OPG levels (OPG protein by ELISA and OPG mRNA levels by PCR) expressed in placental tissue between preeclampsia patients and healthy control groups, it was found that there was high significant difference (p ≤ 0.01) between preeclampsia and normal patients. So the OPG levels in placenta can discriminate between preeclampsia and control healthy group. And results showed that changes in each group were very observable, Both OPG protein and mRNA levels were high significantly different in severe cases of preeclampsia than those mild cases.These indicated that the changes of OPG levels were more obvious in severe preeclampsia, suggesting that expression of OPG were consistent with the severity of preeclampsia.
Conclusion: OPG expression in placenta can discriminate between preeclampsia and control healthy group. Also , OPG levels were more obvious in severe preeclampsia, suggesting that expression of OPG were consistent with the severity of preeclampsia but were not correlated or predicting to complication related to preeclampsia or fetal weight.